Velde, N V <br/><br/>
The benefits of timely intervention with zoledronic acid in patients with metastatic prostate cancer to bones: a retrospective study of the US Veterans Affairs population.  [electronic resource] 

 -  Prostate cancer and prostatic diseases  Mar 2011 
 - 79-84 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1476-5608 
<br/><br/><label>Standard No.: </label>10.1038/pcan.2010.49  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Antineoplastic Agents--administration & dosage<br/>Bone Neoplasms--drug therapy<br/>Diphosphonates--administration & dosage<br/>Hospitalization--statistics & numerical data<br/>Humans<br/>Imidazoles--administration & dosage<br/>Kaplan-Meier Estimate<br/>Male<br/>Middle Aged<br/>Prostatic Neoplasms--drug therapy<br/>Retrospective Studies<br/>Risk Assessment<br/>Time Factors<br/>Treatment Outcome<br/>United States<br/>United States Department of Veterans Affairs<br/>Zoledronic Acid